Articles Published in 2011

Merge Healthcare names senior executives

Thursday, November 10, 2011 09:52 AM

More... »

inVentiv expands services to Korea

Thursday, November 10, 2011 09:28 AM

inVentiv Health has established inVentiv Health Korea, a Seoul-based operation that will provide clinical development and commercial services to healthcare clients.

More... »

Clinilabs selects NewCardio's QTinnoŽ solution for phase I trial

Thursday, November 10, 2011 08:12 AM

NewCardio, a cardiovascular diagnostic solutions developer, has reported that its strategic partner, Clinilabs, will utilize QTinnoŽ, NewCardio's automated cardiac safety solution, to conduct a phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.

More... »

Ablynx, Merck expand partnership

Wednesday, November 9, 2011 03:08 PM

Ablynx has further expanded its relationship with Merck Serono and entered into a third agreement to co-discover and co-develop Nanobodies against two targets in osteoarthritis. The companies will exploit the unique Nanobody features and will develop multi-specific products, which have extended half-lives.

More... »

Rempex raises $67.5 million in Series B financing

Wednesday, November 9, 2011 02:06 PM

Rempex Pharmaceuticals has completed the initial closing of a Series B financing.  New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences, OrbiMed Advisors and Adams Street Partners in committing to a total of $67.5 million for this round.  This financing, together with a previous Series A round, brings the total financing commitment for Rempex to $76 million since the company's founding in June 2011.

More... »

Abcodia, Oxford Gene Technology partner to advance pancreatic cancer biomarkers

Wednesday, November 9, 2011 08:42 AM

Abcodia, a company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases, and Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, have signed a collaboration aimed at improving the early detection of pancreatic cancer.

More... »

Rhythm names CEO

Wednesday, November 9, 2011 08:34 AM

Rhythm, a biotechnology company, has named Keith M. Gottesdiener, MD, chief executive officer.

More... »

NeuroDerm's Parkinson's trial meets primary endpoints

Wednesday, November 9, 2011 08:24 AM

NeuroDerm has reported the results of a phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet-CR, Sinemet or Stalevo, in patients with advanced Parkinson's disease. ND0611 is a proprietary carbidopa liquid formula administered sub-cutaneously via a dermal patch to increase the bioavailability and efficacy of orally- administered levodopa. Results of this study support the continued development of ND0611 for the treatment of Parkinson's disease.

More... »

ICON, Empire Genomics partner to develop personalized medicines

Wednesday, November 9, 2011 08:02 AM

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Empire Genomics, a provider of genomic technologies that enable personalized medicine to be realized, have formed a strategic alliance.

More... »

Hoffman joins Theorem Clinical Research

Tuesday, November 8, 2011 03:35 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Marc Hoffman, MD, senior vice president and general manager for their newly formed pharmaceutical development business unit. In his new role, Hoffman will have strategic oversight for Theorem’s core CRO operation, including project management, clinical monitoring, SMART (site management and patient recruitmenT), and pharmaceutics. He will also oversee the company’s medical operations. 

More... »